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other health care providers that
voluntarily form networks to improve
the quality of health care services and
reduce health care costs for a clearly
defined patient population. 3,4
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National health care expenditures are continuously rising, accounting for 17.9 percent of the gross domestic product (GDP) in 2011
1
and expected to rise to 19.6 percent of GDP in 2021. This demonstrates the growing need to find solutions to slow down spending
on health care while maintaining and even improving quality of care. The Patient Protection and Affordable Care Act (generally
known as the Affordable Care Act, or ACA) enacted in March 2010 authorized the Centers for Medicare and Medicaid Services
2
(CMS) to contract with accountable care organizations (ACOs) to address these issues. This article will define and provide characteristics of what an ACO is, how they will get reimbursed, challenges that exist to their implementation, and what role pharmacists
have in these new and upcoming health care organizations to provide high quality of care while controlling costs.
Accountable care organizations are groups of physicians, hospitals and other health care providers that voluntarily form networks
to improve the quality of health care services and reduce health care costs for a clearly defined patient population. 3.4 These providers are held jointly accountable for quality improvements of patient care and spending growth reductions. 5 Accountable care organizations emerged from the concept that physicians who are tied to a hospital already function as a network and take care of
patients within that hospital system. Now, these once informal networks can become formal so that public and private payers can
4
hold these systems accountable for the outcome of care. The three goals of an ACO are to promote integration among health care
professionals to provide better care for individuals, improve the health of the population and reduce the growth rate in health care
expenditures. This promotion of continuity across the health care continuum ensures that patients are treated in a convenient and
cost-effective manner, while the enhanced communication amongst health care professionals contributes to a reduction in unnec2
essary hospital admissions and readmissions, procedures and duplicate therapies.
A group of health care providers can qualify as an ACO in one of five categories under the Medicare Shared Savings Program:
1) group practices, 2) independent practice associations (IPAs) or other networks of individual practitioners, 3) hospital and professional joint ventures or partnership, 4) hospitals that employ ACO professionals or 5) any other group approved by the Department
4
of Health and Human Services secretary. Regardless of the variations of health care providers comprising the group, each ACO
must promote evidenced-based medicine, patient engagement, coordination of care and report quality and cost metrics. 2 0ne of
the most prominent characteristics of an ACO is the shift of accountability from insurers to providers, giving providers financial
6
incentives to cooperate and save money by avoiding unnecessary tests and procedures. An ACO will work to bring the different
components of health care delivery together, such as primary care, specialists and hospitals, to ensure that all the parts work and
fit together effectively. In order to encourage patients and payers to buy into the idea of ACOs, this model will need to prove that
the overall health care product they are creating actually does improve quality and lowers cost. 6
In an effort to ensure a large enough sample size and sufficient time to gather meaningful performance measurements, there are
required elements that must be met to become an ACO. All ACOs must agree to a three-year contract and must serve an assigned
4
population of at least 5,000 patients. This may mean that rural or smaller-scale hospitals must form partnerships amongst themselves in order to jointly reach the required 5,000 patients. Each ACO must also have a formal legal structure allowing it to receive
and distribute shared payment. An additional requirement is having a governing body responsible for the oversight and strategic
direction of an ACO, which is composed of at least one ACO beneficiary without conflict of interest, an executive/officer who man2
ages operations and a medical director who is the physician in charge of clinical management.
Since the concept of ACOs is fairly new, many organizations creating ACOs do not yet have sufficient data to produce valid quality
measures or benchmarks of success to evaluate the performance standards of an ACO. Until enough meaningful data is obtained to
provide a systematic evaluation, certain core elements of ACOs can be used to give a rough assessment of ACO success: improving
patient care, providing better health for the population and reducing overall spending growth. 7 For current ACO models, payers
collect data over a given period of time on their ACO's costs for their patient population, as well as quality of care and population
health measures. The ACOs are held accountable by whether or not they provide high quality care while reducing unnecessary
costs. Some ACOs may require their providers to meet minimum quality standards in order to continue to participate in the network.4 An ACO will be deemed successful in cost reductions based on a spending benchmark set for each ACO based on its beneficiaries' previous expenditures. If the ACO keeps its spending growth below the average per capita spending growth for all benefici4
aries, it will have been deemed to have achieved savings.
Though many details of ACO programs have yet to be established, it has been suggested that a three-tiered reimbursement program be implemented. In this approach, there are three levels of ACOs with increasing degree of responsibility and risk. Simply put,
the greater financial risk invested, the more potential reward the ACO receives of shared savings. Those ACOs operating under the
2
higher risk tiers would be permitted to keep a larger portion of the savings it provides its payer. Tier 1 is a low financial risk tier,
with fee-for-service payment. Tier 2 displays moderate financial risk, with fee-for-service, partial capitation and some bundled payment methods. Tier 3 is the highest level of financial risk, with full or partial capitation and extensive bundled payments. This third
4
tier provides the highest amount of shared savings and bonuses.
The driving force behind the ACOs' patient-centric approach is an emphasis on quality of care instead of quantity. 2 In this new pay
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for performance model, health care providers are rewarded for
efficient use of health care and coordination of care. 4 If an ACO
improves patient care and reduces the cost of that care, it will
3
share in the savings it achieves for its payer. To provide stronger
incentives, there are no negative risks to participation (at least in
the beginning of implementation) an ACO will not share in any
4
losses if treatment of patients costs more than expected. This is
implemented by the first performance year's quality reporting
standard being merely pay for reporting. This means that ACOs
will receive full credit for quality reporting as long as they accurately submit the measures. However, in the second performance
year, pay-for-performance for these measures will be phased in. If
an ACO fails to report quality measure data accurately, completely and on a timely basis, they may be subject to termination or
8
other sanctions.

Therefore1 the obstacle for pharmacists is not only to find emerging
ACOs1 but to reach out and convince
the health care professionals in the
ACO that pharmacy is essential for
overall cost reduction in the ACOs.

~~~~~~~~~~~~~~~~~~~~~~~--:

The CMS finalized new rules under the ACA establishing the Shared Savings Program under which doctors, hospitals and other
health care providers may work together to better coordinate care for Medicare patients through an ACO. The Shared Savings Program will reward ACOs that lower their growth in health care costs while meeting the quality performance standard. If quality
measures are met and savings are achieved, a percentage of that savings is shared back with the ACO. How savings will be divided
4
amongst the providers is to be determined by each AC0. Before an ACO can share in any savings generated, it must meet the
quality performance standard. To do so, CMS will measure and report quality of care using 33 measures in four key domains:
1) patient and caregiver experience, 2) care coordination and patient safety, 3) preventive health and 4) at-risk populations. By
8 9
improving this quality of care for individuals, better overall health for the population is expected. '
There are several challenges that pharmacists must overcome in order to be incorporated into the ACO health care structure. The
7
first obstacle to pharmacists' incorporation into ACOs is defining and establishing an appropriate path forward. As ACOs are still
new, the path for pharmacists to join these organizations is not yet established. ACOs are still struggling to discover an ideal system
for patient care, which includes determining which health care providers should be included in order to have the best outcomes.
Therefore, the obstacle for pharmacists is not only to find emerging ACOs, but to reach out and convince the health care professionals in the ACO that pharmacy is essential for overall cost reduction in ACOs. Pharmacists are already utilizing and being
reimbursed for medication therapy management (MTM) services, including comprehensive medication reviews and preventative
2
counseling, which have been shown to significantly reduce health care costs and improve patient outcomes. Since these are the
goals for ACOs, it seems obvious that pharmacists should be included in the organization, but pharmacists need to convince emerging ACOs of their value. It is essential that pharmacists are recognized for the benefits that arise from providing MTM services in
2
order to guarantee a position for pharmacists in the future of health care.
The second challenge is the need for useful performance measures, including measures from a quantitative and qualitative perspective.7 Once pharmacists have overcome the first challenge and are included in ACOs, they need a reliable method by which
performance can be evaluated. Quantitatively, this could include studies that determine the number of hospital stays for patients
that receive pharmacist counseling regularly through their ACOs versus those patients who do not. These studies would demonstrate the pharmacists' value to ACOs, as well as reveal areas of patient care in which pharmacists could be utilized to improve patient outcomes and reduce health care costs.
Qualitative measures of pharmacists' performances are also important to determine improvement of patient outcomes and patient
-reported satisfaction with the ACO. Methods for these studies could include patient surveys or rates of membership in an ACO.
Receiving patient feedback is vital to ensure that patient goals and ACO goals are both being met for overall health care. As versatile members of the health care team, pharmacists can help to improve patient satisfaction and ACO effectiveness if there is a way
to measure how patients view their health care experiences. ACOs as a whole will be evaluated and reimbursed based on effectiveness, making measures of pharmacists' performance important in order to fully employ their expertise to improve the ACO's success.
7
The final challenge for pharmacists' incorporation into ACOs is to form a reimbursement plan for pharmacy services. Pharmacists
and all other health care providers will share in this challenge as the whole health care structure undergoes massive changes to
move toward coordinated care. The CMS has several programs in place to help ACOs get started and function through the first year
before significant profits are made, and many ACOs contract with an outside payer to receive quality payments or direct financial
support. However, the system needs to be set up so that when the ACO receives payment, each health care professional, including
7
pharmacists, receives their portion of the payment as wel I.
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Options for pharmacists' reimbursement include fee-for-service plans, capitation payment plans, and bundled payment systems. 10
In fee-for-service plans, pharmacists would receive reimbursement for individual services provided to each patient. The specific fee
for each service could vary depending on the type of intervention, but would be a fixed amount that was previously decided upon
by the ACO. Examples include a relatively large fixed amount paid to pharmacists for each comprehensive medication review (CM R)
done with a patient, but a smaller amount paid for every patient a pharmacist counsels on a medication. In the fee-for-service plan,
pharmacists would document and bill every intervention made directly to the ACO. In capitation payment plans, pharmacists would
receive a fixed amount per patient they serve covering a predetermined time period; that is, pharmacists would receive a certain
amount of money based on the number of patients enrolled in the ACO. Lastly, in bundled payment plans, a comprehensive payment for patient care from multiple health care providers is bundled together in one sum to the ACO and is then distributed to the
10
providers. In all three models, pharmacists are paid by their ACOs, but the major difference is the time at which the pharmacist
receives payment. With a fee-for-service or capitation payment plan, pharmacists would receive payment up front for anticipated
service to patients, while pharmacists in a bundled system would receive payment once the ACO is reimbursed after patient care
has already occurred.
The obstacle with these payment plans is that pharmacists need to demonstrate their value of lowering patient health care costs
and improving patient outcomes in order to receive enough compensation for their services and their fair portion from the ACO's
profits. It is important to remember that as pharmacists optimize medication therapy regimens, short-term prescription costs may
increase, but long-term health care costs will decrease with improved disease state management. In order to be compensated for
their part in reducing overall costs, pharmacists need to be informed on payment systems to reimburse the ACO as a whole, as well
as the system by which the ACO plans to reimburse providers.
The two main goals of
ACOs are to improve the
quality and reduce the
costs of health care. In
order to achieve these
goals, ACOs will need to
improve medication and
chronic
disease
state
management, as well as
reduce hospital readmissions.5 In the United
States, chronic diseases
account
for
approximately 75 percent of
health
care
expendi2
tures. Furthermore, 32
percent of adverse events
leading to hospitalizations
8
are due to medications.
Pharmacists have the
capabilities to help ACOs
meet their objectives and
have the potential to play
a huge role within ACOs.
Pharmacists also have the
clinical expertise to help
patients optimize appropriate medication use,
reduce medical related
problems, and improve health outcomes through the delivery of patient care services, such as MTM, health promotion and educa5
tion, and disease prevention and mitigation.

\

An ACO must demonstrate that it delivers high quality of care by meeting the quality performance standards set by CMS before
they can share in any savings. There are many specific ways that pharmacists can help ACOs meet the four domains of performance
standards outlined previously. In the first domain, patient and caregiver experience of care, pharmacists can have an impact on
providing timely care, appointments and information to patients. They can also positively affect health promotion and education,
augment decision making between clinicians and patients and improve health and functional status of individuals. Within the secAccountable Care Organizations: What Pharmacists Should Know
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ond domain, care coordination and patient safety, pharmacists can play a role in decreasing admissions due to ambulatory cond itions, such as chronic obstructive pulmonary disease and congestive heart failure, reducing hospital readmissions and providing
medication reconciliation after discharge from an inpatient facility. Pharmacists' roles in the preventative health domain in elude
influenza and pneumococcal vaccination, tobacco use assessment and cessation intervention and blood pressure checks.
Additional pharmacist responsibilities in this domain include lifestyle and disease state management. The fourth domain's at risk
population consists of patients with diabetes, hypertension, ischemic vascular disease, heart failure and coronary artery disease.
Pharmacists can provide these patients with disease state management and MTM. As health care professionals, pharmacists have
the knowledge and skills to assist ACOs in meeting their performance standards and will be a key component within this new
8
model of health care.
Pharmacists will be a very valuable member to the health care team within ACOs. There are many different ways that they can improve medication therapy outcomes, while also reducing health care costs in the inpatient and outpatient setting. When a patient
is admitted to the hospital, a pharmacist can review the patient's medications and recommend to the physician initial drug regi5
mens or medication changes that need to be made. This will ensure that the patient is receiving the appropriate drug therapy due
to their medical conditions. Additionally, it will reduce medication related adverse events, which can be expensive and cause many
hospital admissions. Before the patient leaves the hospital, the pharmacist should be actively involved in the patient's discharge
planning. Pharmacists can counsel patients on their new medication regimens and answer any questions patients have before be2
ing discharged. Ultimately, this would help prevent hospital readmissions which are very costly to the health care system.
By evaluating medication therapies for drug interactions, allergies, dose adjustments, adverse events, therapeutic duplications,
cost-effective medications and adherence trends, pharmacists can be extremely beneficial to ACOs within outpatient facilities. 11
They are often recognized as medication experts and can effectively perform MTM. Pharmacists can be involved in drug therapy
management clinics, such as anticoagulation or HIV clinics. They can provide comprehensive medication reviews and medication
reconciliations to patients with chronic disease states, which can be difficult for patients to manage on their own. During MTM
8
sessions, pharmacists can counsel nonadherent patients in order to increase their compliance. Overall, MTM encounters would
increase patients' knowledge about their medical conditions and drug therapy, decrease costly adverse events and hospital admissions and improve the quality of patient care. Additionally, just as pharmacists in the inpatient setting have access to a patient's
medical records, it is very important that outpatient pharmacists have similar access to obtain a complete medical understanding
of the patient. Developing an integrated electronic medical record {EMR) that can be accessed in whatever setting the patient receives care is a major component of ACOs. Generating an accurate and comprehensive medication profile for patients would be a
5
way that pharmacists could contribute to EM Rs. Pharmacists in the outpatient setting are a key component to ACOs because of
their accessibility to the public. They are one of the most accessible health care professionals and directly impact patient care .
It is essential that pharmacists collaborate with all health care professionals to improve the quality of health care and reduce costs
within ACOs. A pharmacist is just one type of clinician across the health care continuum who can contribute to the success of ACOs.
It is important that pharmacists become knowledgeable about their role within ACOs so that they can educate physicians, insurance companies, patients and legislators about the value of pharmacy services within ACOs.
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